A detailed history of Bank Of Montreal transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 11,830 shares of HRMY stock, worth $379,269. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,830
Holding current value
$379,269
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$32.18 - $40.46 $380,689 - $478,641
11,830 New
11,830 $392,000
Q2 2023

Aug 02, 2023

BUY
$30.5 - $37.4 $2.43 Million - $2.98 Million
79,754 New
79,754 $2.81 Million
Q2 2022

Aug 11, 2022

SELL
$33.54 - $52.15 $204,090 - $317,332
-6,085 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$33.14 - $51.13 $5,468 - $8,436
165 Added 2.79%
6,085 $307,000
Q4 2021

Feb 11, 2022

BUY
$34.09 - $43.91 $201,812 - $259,947
5,920 New
5,920 $263,000

Others Institutions Holding HRMY

About Harmony Biosciences Holdings, Inc.


  • Ticker HRMY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,161,400
  • Market Cap $1.9B
  • Description
  • Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...
More about HRMY
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.